FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCI2NA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
How Efficient Are Monte Carlo Calculations Together With the Q-System to Determine Radioactive Transport Limits? Case Study on Medical Radionuclides, Maietta M, Haddad F, Avila S., Front Med. 13 juill 2022;9:675009.
https://doi.org/10.3389/fmed.2022.675009Proton Irradiations at Ultra-High Dose Rate vs. Conventional Dose Rate: Strong Impact on Hydrogen Peroxide Yield, Blain G, Vandenborre J, Villoing D, Fiegel V, Fois GR, Haddad F, et al., Radiation Research, June 8, 2022.
https://doi.org/10.1667/RADE-22-00021.1
our news
PRISMAP training course : Translational research of radiopharmaceuticals
19/09/22
Would you tell us about REPARE?
07/09/22
Are you doing your internship at Arronax?
03/08/22
A Lebanese delegation welcomed in Arronax
18/07/22
A look back at the 1st edition of the ISI NucMed thematic school
06/07/22
